Ober-Ramstadt, Germany

Klaus-Otto Minck


Average Co-Inventor Count = 4.9

ph-index = 11

Forward Citations = 500(Granted Patents)

Forward Citations (Not Self Cited) = 476(Oct 12, 2025)


Inventors with similar research interests:


Location History:

  • Darmstadt, DE (1980)
  • Ober-Ramstadt, DE (1984 - 2000)

Company Filing History:


Years Active: 1980-2000

Loading Chart...
51 patents (USPTO):Explore Patents

Title: Klaus-Otto Minck: A Pioneer in Pharmaceutical Innovations

Introduction

Klaus-Otto Minck, based in Ober-Ramstadt, Germany, is a renowned inventor in the pharmaceutical field. With an impressive portfolio of 51 patents, he has made significant contributions to the development of innovative drugs and treatments. His work primarily focuses on compounds that have the potential to combat various cardiovascular diseases.

Latest Patents

Among his notable patents, Minck has developed imidazopyridine derivatives and pharmacologically acceptable salts that exhibit antagonistic properties towards angiotensin II. These innovative compounds hold promise for the treatment of hypertension, aldosteronism, and cardiac insufficiency. This breakthrough reflects his commitment to enhancing therapeutic options in the realm of cardiovascular health.

Career Highlights

Throughout his career, Klaus-Otto Minck has been associated with the esteemed Merck Patent GmbH, where he has played a vital role in advancing pharmaceutical research. His extensive experience in the industry has positioned him as a key figure in the development and patenting of novel therapeutic agents.

Collaborations

Minck has collaborated with distinguished professionals, including Norbert Beier and Dieter Dorsch, further emphasizing the collaborative nature of advancements in pharmaceutical innovations. These partnerships have allowed for a cross-pollination of ideas and expertise, leading to more robust developments in drug discovery.

Conclusion

Klaus-Otto Minck stands out as a pivotal inventor whose work in pharmaceutical innovations continues to impact the healthcare sector positively. His array of patents illustrates a dedication to improving treatment options and enhancing patient outcomes, solidifying his legacy in the world of pharmaceutical sciences.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…